Switching to a Second Thiopurine in Adult and Elderly Patients With Inflammatory Bowel Disease: A Nationwide Study From the ENEIDA Registry.

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Calafat M.
  • Mañosa M.
  • Mesonero F.
  • Guardiola J.
  • Mínguez M.
  • Vera I.
  • Taxonera C.
  • Iglesias E.
  • Ricart E.
  • Gisbert J.P.
  • Calvet X.
  • García-López S.
  • Monfort D.
  • Pérez Calle JL
  • Riestra S.
  • Gomollón F.
  • Garcia-Planella E.
  • Bermejo F.
  • Hernández V.
  • Martín-Arranz M.D.
  • Gutiérrez A.
  • Torres P.
  • Cañete F.
  • Domènech E.

Grupos

Abstract

Although commonly used in inflammatory bowel disease [IBD], thiopurines frequently cause intolerance, and switching to a second thiopurine has only been reported in some small series. Ours aims in this study were to evaluate the safety of switching to a second thiopurine in a large cohort, and to assess the impact of age on tolerance.

Datos de la publicación

ISSN/ISSNe:
1873-9946, 1876-4479

Journal of Crohns & Colitis  OXFORD UNIV PRESS

Tipo:
Article
Páginas:
1290-1298
PubMed:
32201893
Enlace a otro recurso:
www.scopus.com
Factor de Impacto:
3,277 SCImago ℠
Cuartil:
Q1 SCImago ℠

Citas Recibidas en Web of Science: 8

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Thiopurine, elderly, inflammatory bowel disease

Campos de Estudio

Cita

Compartir